Consolidated Statements Of Earnings - USD ($) shares in Thousands, $ in Thousands	3 Months Ended			9 Months Ended
	Sep. 30, 2015		Sep. 30, 2014	Sep. 30, 2015		Sep. 30, 2014
Revenues	$ 712,719		$ 555,543	$ 2,058,649		$ 1,093,331
Provision for uncollectibles				(212,546)		(69,715)
Net revenue	650,227		502,350	1,862,622		1,040,138
Operating expenses:
Salaries and benefits	327,532		240,337	950,107		406,539
Supply cost	45,638		41,886	134,012		120,564
Other operating expenses	98,852		81,262	294,424		191,243
Transaction costs	2,107		25,102	5,560		28,681
Depreciation and amortization	24,106		20,838	70,536		37,533
Total operating expenses	498,235		409,425	1,454,639		784,560
Net gain on deconsolidations	9,112		0	5,854		3,411
Equity in earnings of unconsolidated affiliates	4,935		2,158	11,575		3,461
Operating income	166,039		95,083	425,412		262,450
Interest expense, net	30,242		39,054	90,671		52,906
Debt extinguishment costs	0		16,887	0		16,887
Earnings from continuing operations before income taxes	135,797		39,142	334,741		192,657
Income tax expense	37,518		22	76,960		25,802
Net earnings from continuing operations	98,279		39,120	257,781		166,855
Net loss from discontinued operations	0		(1,697)	0		(1,146)
Net earnings	98,279		37,423	257,781		165,709
Less net earnings attributable to noncontrolling interests	55,618		47,257	160,407		139,387
Net earnings (loss) attributable to AmSurg Corp. shareholders	42,661		(9,834)	97,374		26,322
Preferred stock dividends	(2,264)		(2,239)	(6,792)		(2,239)
Net earnings (loss) attributable to AmSurg Corp. common shareholders	40,397		(12,073)	90,582		24,083
Amounts attributable to AmSurg Corp. common shareholders:
Earnings (loss) from continuing operations, net of income tax	40,397		(10,697)	90,582		25,466
Loss from discontinued operations, net of income tax	0		(1,376)	0		(1,383)
Net earnings (loss) attributable to AmSurg Corp. common shareholders	$ 40,397		$ (12,073)	$ 90,582		$ 24,083
Basic earnings (loss) per share attributable to AmSurg Corp. common shareholders:
Net earnings (loss) from continuing operations (usd per share)	$ 0.85		$ (0.23)	$ 1.90		$ 0.70
Net earnings (loss) from discontinued operations (usd per share)	0.00		(0.03)	0.00		(0.04)
Net earnings (loss) (usd per share)	0.85		(0.26)	1.90		0.66
Diluted earnings (loss) per share attributable to AmSurg Corp. common shareholders:
Net earnings (loss) from continuing operations (usd per share)	0.83		(0.23)	1.89		0.69
Net earnings (loss) from discontinued operations (usd per share)	0.00		(0.03)	0.00		(0.04)
Net earnings (loss) (usd per share)	$ 0.83		$ (0.26)	$ 1.89		$ 0.65
Weighted average number of shares and share equivalents outstanding:
Basic (in shares)	47,707		46,320	47,652		36,620
Diluted (in shares)	51,275		46,320	48,050		37,026
Physician Services [Member]
Provision for uncollectibles	$ (62,492)		$ (53,193)	$ (196,027)		$ (53,193)
Net revenue	$ 341,244	[1]	$ 225,931	$ 958,738	[1]	$ 225,931

[1] On July 16, 2014, we completed the acquisition of Sheridan. As such, historical amounts for periods prior to that date are not included.